Vascular effects of the lercanidipine/enalapril combination: clinical relevance

Research output: Contribution to journalComment/debatepeer-review


Hypertension is associated with alterations in the vascular structure, which in turn enhance the risk of cardiovascular events. Notably, anti-hypertensive treatment may prevent or regress the changes of arterial wall structures. Lercanidipine is a third-generation CCB with peculiar pharmaceutical properties. Enalapril is an effective drug acting on the renin–angiotensin–aldosterone axis. This commentary discusses the vascular effects of the lercanidipine/enalapril combination, and comments on their potential clinical relevance.

Original languageEnglish
Pages (from-to)25-28
Number of pages4
JournalCurrent Medical Research and Opinion
Publication statusPublished - Sep 30 2016


  • Hypertension
  • Lercanidipine
  • Microcirculation
  • Stiffness
  • Vascular effects

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Vascular effects of the lercanidipine/enalapril combination: clinical relevance'. Together they form a unique fingerprint.

Cite this